Evonik Industries
Search Search

Skip over generic navigation

  • Evonik worldwide
  • Language
    • English
    • Deutsch

Skip over primary navigation

Global Website | HOMEGlobal Website | HOME
  • CompanyCompany
  • Products & SolutionsProducts & Solutions
  • ResponsibilityResponsibility
  • Investor RelationsInvestor Relations
  • MediaMedia
  • CareerCareer

Skip over visual

Investor Relations
Investor Relations


  • Investor Relations

Skip over functional column

  • The Company
  • Corporate Governance
  • News & Reports
  • Bonds & Rating
  • Contact & Service

Investor Relations

Dr. Wolfgang Colberg
Dr. Wolfgang Colberg (CFO):

"Our strategy is focused on profitable growth and steadily increasing the value of the company. We believe that transparency, reliability and trust are particularly important and therefore strive for open dialogue with all capital market participants."

 

Finance calendar

Financial Press Conference

March 14, 2012

 

Investor Relations News

  • Evonik plans to invest up to €100 million in venture capital activities over the medium term (01-20-2012)
  • Major investment in Singapore: Evonik to build a new methionine production complex for roughly €500 million (01-20-2012)
  • Evonik plans to build a new production plant for cosmetic ingredients in Brazil (01-20-2012)

Further information

Annual Report 2010
Annual Report 2010

more


  • Statement Dr. Engel - Financial Press Conference 2011
  • Statement Dr. Colberg - Financial Press Conference 2011
  • Charts Dr. Colberg - Financial Press Conference 2011

Disclaimermore

 
  • Downloads
  • Contact
  • Sitemap
  • Company information
  • Legal notice
  • Privacy policy
  • Print
  • Send this page